Lakefront Biotherapeutics (LKFT) Short term Debt (2019 - 2025)

Lakefront Biotherapeutics (LKFT) has 6 years of Short term Debt data on file, last reported at $5820.2 in Q4 2025.

• Short term Debt for Q4 2025 came in at $5820.2, up 8.93% year-over-year; the trailing twelve-month figure through Dec 2025 was $5820.2 (up 8.93% YoY), and the FY2025 annual result was $5820.2, up 8.93% from the prior year.
• Short term Debt improved to $5820.2 in Q4 2025 per LKFT's latest filing, from $5343.0 in the prior quarter.
• Over five years, Short term Debt peaked at $436589.4 in Q1 2022 and troughed at $5343.0 in Q4 2024.
• A 4-year average of $217151.6 and a median of $233370.1 in 2021 frame the typical range for Short term Debt.
• The sharpest annual moves came in 2021 and 2025: Short term Debt plunged 98.66% in 2021, then gained 8.93% in 2025.
• A 4-year view of Short term Debt shows it stood at $233370.1 in 2021, then jumped by 87.08% to $436589.4 in 2022, then sank by 98.78% to $5343.0 in 2024, then advanced by 8.93% to $5820.2 in 2025.
• Business Quant data shows LKFT's Short term Debt at $5820.2 in Q4 2025, $5343.0 in Q4 2024, and $436589.4 in Q1 2022.